HOWARD R. YEATON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TNF Pharmaceuticals, Inc.

Filing Date Source Excerpt
2019-02-05 In connection with his appointment as the Chief Executive Officer and interim Chief Financial Officer of the Company, the Company and Mr. Yeaton entered into an offer of employment, dated October 5, 2018.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25